首页> 外文期刊>海南医科大学学报(英文版) >Prediction of relapse after antithyroid drug therapy of hyperthyroidism through assessment of peak systolic velocity of superior thyroid artery
【24h】

Prediction of relapse after antithyroid drug therapy of hyperthyroidism through assessment of peak systolic velocity of superior thyroid artery

机译:通过评估甲状腺上动脉的峰值收缩速度来预测甲状腺功能亢进的抗甲状腺药物治疗后的复发

获取原文
获取原文并翻译 | 示例
           

摘要

Objective:To explore whether assessment of peak systolic velocity of superior thyroid artery can predict relapse after anti-thyroid drug therapy of hyperthyroidism.Methods:Seventy patients with hyperthyroidism were recruited and treated with antithyroid drug according to the national guideline, the thyroid and superior thyroid artery were evaluated by color Doppler ultrasound, and the blood velocity was measured and analyzed. 30 people with euthyroid were selected as control.Results: Twenty-six of 70 patients with hyperthyroidism treated with anti-thyroid drug relapse six months after remission, accounting for 37.1%. There was no significant difference between relapse patients and patients without relapse for peak systolic velocity of pretreatment. The peak systolic velocities were significant difference between remissive and relapse patients. The MV1-MV2/MV1s was significant difference between remissive and relapse patients. Area under ROC curve of peak systolic velocities of the superior thyroid arteries of relapse patients and euthyroid subjects was 0.773, the cutoff point was 40.3 cm/s, and sensitivity and specificity were 84.6% and 65.0%, respectively. Area under ROC curve of MV1-MV2/MV1s of the superior thyroid arteries of remissive patients and relapse patients was 0.870, the cutoff point was 0.525, and sensitivity and specificity were 86.4% and 69.2%, respectively.Conclusion: The determination of peak systolic velocity of superior thyroid artery and relevant parameters can help predict relapse after anti-thyroid drug therapy of hyperthyroidism.
机译:目的:探讨评估甲状腺上动脉峰值收缩速度是否可以预测甲状腺功能亢进症抗甲状腺药物治疗后的复发。方法:根据国家指南,招募70例甲状腺功能亢进患者并接受抗甲状腺药物治疗通过彩色多普勒超声评估动脉,并测量和分析血流速度。结果以甲亢患者30例为研究对象。结果:70例甲亢患者中有26例接受抗甲状腺药物治疗后6个月复发,占37.1%。复发患者和未复发患者之间的预处理峰值收缩速度没有显着差异。收缩期和复发期患者的最高收缩速度差异显着。 MV1-MV2 / MV1s在缓解和复发患者之间有显着差异。复发患者和甲状腺功能正常者的甲状腺上动脉峰值收缩速度的ROC曲线下面积为0.773,临界点为40.3 cm / s,敏感性和特异性分别为84.6%和65.0%。缓解期和复发期甲状腺上动脉MV1-MV2 / MV1s的ROC曲线下面积为0.870,临界点为0.525,敏感性和特异性分别为86.4%和69.2%。结论:测定收缩期峰值甲状腺上动脉的速度和相关参数可以帮助预测甲状腺功能亢进的抗甲状腺药物治疗后的复发。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2018年第5期|76-79|共4页
  • 作者单位

    Department of Ultrasound, the First Affiliated Hospital of Hainan Medical College, Haikou 570102, China;

    Department of Ultrasound, the First Affiliated Hospital of Hainan Medical College, Haikou 570102, China;

    Department of Endocrinology, the First Affiliated Hospital of Hainan Medical College, Haikou 570102, China;

    Department of Ultrasound, the First Affiliated Hospital of Hainan Medical College, Haikou 570102, China;

    Department of Ultrasound, the First Affiliated Hospital of Hainan Medical College, Haikou 570102, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号